Growing Demand for Self-Injection Devices in Healthcare

| January 29, 2025

LinkedIn LinkedIn

The self-injection devices market has witnessed tremendous growth in recent years, driven by the increasing prevalence of chronic diseases, advancements in medical technology, and the rising demand for self-administration of medications. Patients are gravitating toward self-injection devices due to their convenience and user-friendliness, which empower individuals to take greater control over their health and treatment.2, 4

This trend is particularly evident in the treatment of obesity, where GLP-1 receptor agonists like Ozempic® and Wegovy® have become transformative forces. These medications are in high demand, fueled by increasing obesity rates in the U.S. and globally. According to the Pew Research Center, as of March 2024, over 42% of American adults are classified as obese, with more than 20 million Americans currently taking GLP-1 drugs.3, 5

A New Era for Weight Loss and Healthcare

The surge in demand for weight loss drugs highlights a growing need to address obesity and its associated health risks. Rising obesity rates, heightened awareness of health implications, and the proven effectiveness of GLP-1 medications have combined to create a transformative moment in the healthcare industry. These medications, supported by widespread media coverage and social media attention, have revolutionized the weight-loss market, offering new hope to millions.

At the same time, advancements in the development and distribution of these medications are paving the way for expanded applications. Early clinical research suggests that GLP-1 drugs could play a role in treating conditions like sleep apnea and substance abuse disorders, further broadening their potential impact.1

Empowering Growth Through Self-Injection Devices

The growing reliance on GLP-1 medications has also driven innovation in the self-injection devices market. Devices like syringes and auto-injectors, which rely on high-performance plastics, are critical for ensuring safe and effective medication delivery. However, the rapid growth of the GLP-1 market has created a competitive environment, with manufacturers racing to meet escalating demand.

Persistent shortages of GLP-1 drugs have also spurred the development of compounded alternatives, many of which use syringes for administration. These trends present opportunities for manufacturers in the medical plastics industry to expand their capabilities and to meet this increasing demand.

 

Nexeo Plastics: Partnering for Innovation

Nexeo Plastics is uniquely positioned to support the growth of this rapidly evolving market. With a robust line card tailored to the healthcare industry, we offer high-quality materials from leading producers in the industry that can be used for medical devices, including those used in self-injection systems. Our team of experts strives to deliver innovative solutions to help manufacturers stay competitive in this dynamic landscape.

As global demand continues to rise—particularly in North America, the largest market, and Asia-Pacific, the fastest-growing region—Nexeo Plastics remains committed to driving innovation and to supporting sustainability initiatives. From at-home medical devices to advanced material solutions, we are your trusted partner for helping you meet today’s healthcare challenges.

For more information about how Nexeo Plastics can support your medical plastics needs, contact our expert healthcare team today, or visit our Healthcare end market page.

 

Sources:

[1] https://www.plasticsnews.com/kickstart/glp-1-growth-fast-recovery-iv-bag-production-buying-plasticscom

[2] https://www.girolino.com/exploring-the-top-trends-in-the-glp-1-weight-loss-market-a-comprehensive-guide/

[3] https://pharmaphorum.com/deep-dive/ozempic-dilemma-balancing-demand-supply-and-patient-safety-viral-glp-1-world

[4] https://markwideresearch.com/self-injection-devices-market/

[5] https://www.pewresearch.org/short-reads/2024/03/21/as-obesity-rates-rise-in-the-us-and-worldwide-new-weight-loss-drugs-surge-in-popularity/

About the Author

Dana McIntyre | End Market Manager - Healthcare

Serving as the End Market Manager for Healthcare, Dana plays a vital role as an extension of the corporate accounts and sales teams. She obtained her MBA in Healthcare Management and has over 19 years of experience in the healthcare industry ranging from biotech, labware, pharmaceuticals, and medical devices to healthcare informatics. Her responsibilities include market research, healthcare strategy development, and liaising with suppliers and OEMs to identify growth opportunities within the healthcare sector.

View Our Technical Team

Follow me on: LinkedIn